BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260513T120000
DTEND;TZID=UTC:20260513T140000
DTSTAMP:20260426T171017
CREATED:20260417T155858Z
LAST-MODIFIED:20260420T144300Z
UID:334964-1778673600-1778680800@healtheconomics.org
SUMMARY:Health spending and outcomes
DESCRIPTION:Add to Calendar! \nThis web workshop will explore the relationship between health spending and health outcomes\, bringing together empirical evidence from a diverse range of country contexts. Presentations will examine whether increased public investment in health translates into measurable improvements in population health\, drawing on case studies from Brazil\, Indonesia\, the United Kingdom\, the United States\, and South Africa\, alongside a systematic review of existing research. The session will provide participants with a deeper understanding of the key methods and theoretical approaches used to evaluate the impact of health expenditure. It will conclude with dedicated time for questions\, answers\, and open discussion\, offering an opportunity for critical reflection and exchange. \nPresentations: \n\n The effect of public health expenditure on health and health care use: a systematic review\n\n \nThis systematic review and meta-regression analysis synthesizes the international literature on the effect of public health expenditure on health and care. Findings highlight the importance of strong governance\, sustainable financing\, and investment in prevention and workforce\, while revealing key gaps in evidence from low- and middle- income countries and in understanding financing mechanisms. \n  \nPresenter: Eliana Chavarría-Pino is a postdoctoral researcher at the Ludwig Maximilian University of Munich. Her work focuses on the evaluation of health policies and programmes in low- and middle-income countries\, with a particular emphasis on health financing and the health workforce. \n  \n\n The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17\n\nThis study examines how different types of NHS spending vary in their ability to generate health gains\, measured in cost per quality-adjusted life year (QALY). Using 2016 data and two-stage least squares\, the authors estimate that locally commissioned services deliver a QALY for around £8\,000\, while results for primary care and specialised services are more uncertain. Accounting for this variation slightly increases the overall estimated cost per QALY across the NHS. The findings suggest that directing additional investment toward primary care and locally commissioned services may yield the greatest health benefits. \nPresenter: James Lomas is a senior lecturer at the Department of Economics and Related Studies at the University of York. His research is focused on applied microeconometric analysis that answers the empirical questions posed in the context of economic evaluation and cost-effectiveness analysis.  \n  \n\n Health system efficiency under fiscal constraint: Spending complementarity and district performance in South Africa\n\n \nThis study evaluates how efficiently public health funds are used across 48 districts in South Africa amid tight fiscal constraints. Using stochastic frontier analysis\, it finds wide variation in efficiency (7%–87%)\, with significant potential to improve health outcomes without increasing spending. Results highlight that primary health care spending is most effective when supported by sufficient hospital capacity\, while hospital spending shows more consistent benefits. The study identifies district performance patterns to guide better resource allocation and peer learning in constrained health systems. \nPresenter: Fouché Venter is Executive Director of Economic Research Southern Africa and an applied economist focused on public economics. His research examines fiscal sustainability\, fiscal frameworks\, and the efficiency and effectiveness of public resource allocation. \n  \n\n Does Increasing Public Spending in Health Improve Health? Lessons from a Constitutional Reform in Brazil\n\nThis presentation discusses how government health spending shapes health outcomes by exploring unique top-down variation generated by Brazil’s 29th Constitutional Amendment\, which mandated minimum thresholds for municipal health spending. It describes how sharp changes in health spending resulting from the Constitutional Amendment affect downstream outcomes\, documenting increases in available resources and access to health at various margins\, with resulting declines in infant mortality and all cause mortality. Secondly\, it discusses the production function of public healthcare\, documenting non-linearities and input complementarities.  A number of key margins of spending effectiveness and constraints to larger gains from health spending are highlighted\, including frictions between bureaucratic capacity and political incentives. \nPresenter: Damian Clarke is a researcher and Associate Professor of Economics at The University of Exeter\, and The University of Chile. His research focuses on maternal and child health\, and family fertility decisions. In particular\, his papers examine the impact of public programs on maternal mortality and morbidity\, early life health outcomes for children\, and the determinants of parental investment in children. \n  \n\n Does increasing overall health expenditure reduce inequality in under-5 mortality rates between provinces in Indonesia?\n\nThis study analyses whether increased public health spending in Indonesia (2004–2012) reduced inequalities in under-five mortality across socioeconomic groups. Using dynamic panel System-GMM and instrumental variables\, it finds that higher spending actually widened inequality\, as wealthier households benefited more from mortality reductions than poorer ones. The study finds no significant difference in impact between provinces with high and low baseline mortality. Overall\, the results suggest that simply increasing health spending is insufficient to reduce inequalities unless funds are better targeted toward disadvantaged populations and high-need areas. \nPresenter: Ivan Ochoa-Moreno is a Research Fellow in Global Health at the University of York. His research focuses on impact evaluation of health policies\, universalisation of healthcare and lifelong impact of early-life health and development. \n  \n\n The Value of Healthcare in the United States: Changes in Lifetime Spending and Health-Adjusted Life Expectancy\, 1996 to 2016\n\nThis study extends prior work on the value of healthcare spending by examining health-adjusted life expectancy (HALE) and lifetime costs across all ages and diseases. Using global burden and expenditure data\, it estimates that healthcare improvements from 1996 to 2016 increased HALE by about 1.3 years at a cost of roughly $182\,000 per HALE gained. Results vary widely by disease\, with substantial gains for conditions like HIV/AIDS and heart disease\, but negative effects for drug use disorders. The findings highlight the importance of evaluating healthcare value across the full life course and by specific causes. \nPresenter: Marcia Weaver\, PhD\, is a Research Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington where she leads the cost-effectiveness research team. She specialises in meta-regression analysis of published cost-effectiveness estimates and has published 103 peer-reviewed articles. 
URL:https://healtheconomics.org/event/health-spending-and-outcomes/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260525T050000
DTEND;TZID=UTC:20260525T060000
DTSTAMP:20260426T171017
CREATED:20260420T172146Z
LAST-MODIFIED:20260420T172146Z
UID:334975-1779685200-1779688800@healtheconomics.org
SUMMARY:A 10-year scoping review: an inspirational or cautionary tale?
DESCRIPTION:Add to Calendar! \nEver started a project that was meant to be ‘quick and straightforward’? In this webinar\, Associate Professor Nikki McCaffrey will share the story behind a scoping review that took almost a decade to complete before publication in Social Science & Medicine. The talk offers a candid\, slightly irreverent look at scope creep\, opportunity cost\, and the hard calls around when to persist\, pivot\, or cut losses. Short\, honest\, and practical\, with reassurance that messy research journeys are far more common than we admit. \nSpeaker: \nAssociate Professor Nikki McCaffrey is a health economist at Deakin University\, Victoria\, Australia and Head of Cancer Economics. She works at the intersection of health economics\, outcomes research and policy\, with a particular focus on cancer\, palliative and end‑of‑life care\, and the often‑overlooked role of informal carers. Nikki has published 100+ peer‑reviewed papers and secured over $20 million in competitive research funding\, leading multidisciplinary teams across Australia and internationally. She is a co‑founder and co‑lead of the International Health Economics Association Special Interest Group on the Economics of Palliative & End‑of‑Life Care\, and is a strong advocate for applied\, decision‑relevant research that actually gets used.
URL:https://healtheconomics.org/event/a-10-year-scoping-review-an-inspirational-or-cautionary-tale/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260528T080000
DTEND;TZID=UTC:20260528T090000
DTSTAMP:20260426T171017
CREATED:20260325T193218Z
LAST-MODIFIED:20260325T193218Z
UID:334808-1779955200-1779958800@healtheconomics.org
SUMMARY:Biobanks and Genomics in Low- and Middle-Income Countries: Emerging Opportunities for Research and Health Economics Webinar & Panel Discussion
DESCRIPTION:Add to Calendar! \nThis panel discussion will feature short presentations from Professor Segun Fatumo (Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit) and Professor Zhu Chen (College of Economics and Management\, China Agricultural University\, Beijing). The speakers will highlight emerging opportunities in biobanks and genomics\, particularly in low- and middle-income country (LMIC) settings. The panel discussion will then explore how biobank and genomic platforms and data can be leveraged to inform health economic analysis and policy decision-making in LMICs\, followed by an open discussion and concluding remarks. \nModerator: Professor Zanfina Ademi\, Monash University \nPresentation 1:\nName: Professor Segun Fatumo\nRole & organization: Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit\nBio: Professor Segun Fatumo is a globally recognised genomic epidemiologist advancing equitable human genomics research. He is Professor and Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit. His work focuses on genetic determinants of cardiometabolic disease and kidney disease in diverse ancestry populations. He leads major initiatives including KidneyGenAfrica\, BCX-Africa and the Nigerian 100K Genome Project\, supported by international funders such as the MRC\, NIH and Wellcome Trust. Professor Fatumo is widely published\, serves on global advisory boards\, contributes to genomics policy and capacity building in Africa\, and is a frequent keynote speaker and media commentator\nAbstract: The Uganda Genome Resource (UGR) is a well-characterized genomic biobank derived from the long-standing Uganda General Population Cohort\, comprising genotype data (~5\,000 individuals) and whole-genome sequencing (~2\,000 individuals) across 10 ethno-linguistic groups. With rich phenotypic data spanning communicable and non-communicable diseases\, UGR provides a unique platform for advancing genomics\, multi-omics integration\, and precision medicine in African populations. It enables discovery of population-specific variants\, improved disease risk prediction\, and deeper biological insights across diverse ancestries. These opportunities position UGR as a critical resource not only for scientific discovery but also for generating evidence to inform cost-effective health economic strategies and policy decisions in LMICs. \nPresentation 2:\nName: Professor Chen Zhu\nRole & organization: College of Economics and Management\, China Agricultural University\, Beijing\nBio: Chen Zhu is a Professor at the College of Economics and Management\, China Agricultural University. She received her Ph.D. in Agricultural and Resource Economics from the University of Connecticut and her B.S. in Biology from Nanjing University. She currently serves as an Associate Editor for Agribusiness and an Editorial Board Member of Scientific Reports. Dr. Zhu has published more than 50 peer-reviewed articles in economics\, public health\, and interdisciplinary journals. Her research focuses on genoeconomics\, integrating genetic and socioeconomic data to better understand human capital formation\, health behaviors\, and economic decision-making\, with particular interest in applications to rural development and health policy in China. Website: https://zhuchencau.wordpress.com/cv/\nAbstract: This talk introduces a pilot Human Capital and Genoeconomics Survey conducted among rural households in China since 2019. The survey combines rich socioeconomic information\, including human capital\, health behaviors\, fertility\, and household decision-making\, with individual genetic data for about 800 participants in rural China. Using this dataset\, she will explore how genomic variation interacts with environmental conditions\, nutrition\, and local economic contexts to shape health and socioeconomic outcomes. She will argue that small- and medium-scale genomic surveys linked to detailed socioeconomic data can complement large biobanks\, offering a practical framework for advancing genoeconomics research and informing health and development policy in low- and middle-income country settings.
URL:https://healtheconomics.org/event/biobanks-and-genomics-in-low-and-middle-income-countries-emerging-opportunities-for-research-and-health-economics-webinar-panel-discussion/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR